ALEMBIC
Back to Income Statement
|
ALEMBIC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹222 Cr | ₹157 Cr | ₹127 Cr | ₹78 Cr | ₹74 Cr |
What is the latest Revenue of ALEMBIC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹222 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹127 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹74 Cr |
How is Revenue of ALEMBIC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹222 Cr | 40.89 | |
| Mar2024 | ₹157 Cr | 23.77 | |
| Mar2023 | ₹127 Cr | 62.68 | |
| Mar2022 | ₹78 Cr | 6.40 | |
| Mar2021 | ₹74 Cr | - | |
Compare Revenue of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,381.8 Cr | -0.8% | -7.2% | -21.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -0.8% |
-7.2% |
-21.3% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses